The MMR gene is closely related to TMZ-associated hypermutation, and a previous study confirmed that MMR gene deficiency leads to hypermutation and chemoresistance in gliomas (Touat et al., 2020). The gene discussed is MRC1; the disease is central nervous system cancer.